Status:
COMPLETED
Study to Investigate Efficacy and Safety of a New Oral Contraceptive
Lead Sponsor:
Bayer
Conditions:
Contraception
Eligibility:
FEMALE
18-50 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to evaluate the safety and effectiveness of a new 4-phasic preparation in the prevention of pregnancies in a large group of volunteers.
Detailed Description
The study has previously been posted by Schering AG, Germany. Schering AG, Germany has been renamed to Bayer Schering Pharma AG, Germany.Bayer Schering Pharma AG, Germany is the sponsor of the trial.
Eligibility Criteria
Inclusion
- Healthy volunteers
Exclusion
- Any condition that might interfere the outcomes
Key Trial Info
Start Date :
April 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2006
Estimated Enrollment :
1392 Patients enrolled
Trial Details
Trial ID
NCT00185289
Start Date
April 1 2004
End Date
July 1 2006
Last Update
July 15 2011
Active Locations (50)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr. Max Stiglbauer
Wiener Neustadt, Lower Austria, Austria, 2700
2
Praxis Dr. Langer
Fürstenfeld, Styria, Austria, 8280
3
Dr. Meusburger
Wolfurt, Vorarlberg, Austria, 6922
4
Landeskrankenhaus Bregenz
Bregenz, Austria, 6900